Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Altimmune, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Altimmune, Inc. | v318145_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - Altimmune, Inc. | v318145_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Altimmune, Inc. | v318145_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Altimmune, Inc. | v318145_ex31-1.htm |
Exhibit 32.2
Certification Pursuant to Section 1350 of Chapter 63
of Title 18 of the United States Code
In connection with the Quarterly Report of PharmAthene, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2012, as filed with the Securities and Exchange Commission (the “Report”), I, Linda Chang, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and | ||
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. | ||
| /s/ Linda Chang | |
| Linda Chang | |
| Senior Vice President and Chief Financial Officer | |
| August 7, 2012 |
A signed original of this written statement required by Section 906 has been provided to PharmAthene, Inc. and will be retained by PharmAthene, Inc. and furnished to the Securities and Exchange Commission upon request.